Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

University of Leicester receives funding from two Masonic charities for heart study

A University of Leicester research project has received vital philanthropic funding for the second year from two Masonic charities.

23 Jul 2014

Right kind of fat keeps the heart healthy

Too much dietary fat is bad for the heart, but the right kind of fat keeps the heart healthy, according to a paper published in The Journal of Experimental Medicine.

22 Jul 2014

Expert guidance offers recommendations for hand hygiene in healthcare facilities

Expert guidance released today offers updated evidence reviews and recommendations for hand hygiene in healthcare facilities.

17 Jul 2014

Expert guidance helps prioritize strategies to prevent VAP

Thousands of critically ill patients on life support develop ventilator-associated pneumonia (VAP) each year. A new document released today by a consortium of professional organizations helps prioritize strategies to prevent this potentially fatal infection.

17 Jul 2014

Potassium supplements with loop diuretics increase survival rates of heart failure patients

Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking prescription potassium supplements together with loop diuretics for heart failure have better survival rates than patients taking diuretics without the potassium. Moreover, the degree of benefit increases with higher diuretic doses.

17 Jul 2014

Freedom portable driver receives FDA approval for use with SynCardia Total Artificial Heart

The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.

16 Jul 2014

Education boosts glycaemic control after diabetes diagnosis

Attending a brief diabetes education programme enhances the glycaemic control achieved by patients newly diagnosed, research suggests.

15 Jul 2014

PAH disease burden ‘significant’

Patients with newly diagnosed pulmonary arterial hypertension have a substantial burden of disease, with more than half hospitalised during the first 3 years post-diagnosis, research shows.

15 Jul 2014

Exeter scientists find health benefits in rotten egg gas

It may smell of flatulence and have a reputation for being highly toxic, but when used in the right tiny dosage, hydrogen sulfide is now being being found to offer potential health benefits in a range of issues, from diabetes to stroke, heart attacks and dementia. A new compound (AP39), designed and made at the University of Exeter, could hold the key to future therapies, by targeting delivery of very small amounts of the substance to the right (or key) places inside cells.

10 Jul 2014

Mercy Memorial Hospital System signs LOI to join Promedica

Mercy Memorial Hospital System signed a letter of intent to join ProMedica, a not-for-profit, multi-hospital system based in Toledo, Ohio.

9 Jul 2014

Doctors offer new minimally invasive system to treat patients with narrowed, failing aortic heart

Doctors at the Orlando Health Heart Institute are offering a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. Orlando Health is the only hospital in Orlando currently offering the Medtronic CoreValve® System.

From Medtronic 8 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Standard risk factors stratify already high-risk diabetic patients

Cardiovascular disease risk factors are associated with mortality even among patients with Type 2 diabetes who are already at high risk due to having high coronary artery calcified plaque, say researchers.

4 Jul 2014

Insulin pumps better than injections for glycaemic control in Type 2 diabetes

Patients with Type 2 diabetes achieve better glycaemic control with insulin pumps than multiple insulin injections, show the findings of the OpT2mise randomised trial.

4 Jul 2014

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

In a study that included nearly 65,000 older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a significantly lower risk of death and a slightly increased risk of heart attack, according to a study in the June 4 issue of JAMA.

4 Jul 2014

Preventive placement of ICDs improves survival in patients with less severe heart failure

An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA.

4 Jul 2014

Researchers discover new way by which metabolism is linked to regulation of DNA

A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.

4 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

Scientists discover 23 new genes linked to heart rhythm

The QT interval is part of the heart's electrical cycle as measured by ECG, and represents the electrical depolarization and repolarization of the ventricles. Lengthened intervals indicate dysfunction in the heart beat and are liable to lead to a five-fold increase in the risk of sudden death from heart failure.

2 Jul 2014

Use of catheter ablation lowers risk for atrial fibrillation

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.

1 Jul 2014

Heart Failure News and Research

Further Reading

University of Leicester receives funding from two Masonic charities for heart study

Right kind of fat keeps the heart healthy

Expert guidance offers recommendations for hand hygiene in healthcare facilities

Expert guidance helps prioritize strategies to prevent VAP

Potassium supplements with loop diuretics increase survival rates of heart failure patients

Freedom portable driver receives FDA approval for use with SynCardia Total Artificial Heart

Education boosts glycaemic control after diabetes diagnosis

PAH disease burden ‘significant’

Exeter scientists find health benefits in rotten egg gas

Mercy Memorial Hospital System signs LOI to join Promedica

Doctors offer new minimally invasive system to treat patients with narrowed, failing aortic heart

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Standard risk factors stratify already high-risk diabetic patients

Insulin pumps better than injections for glycaemic control in Type 2 diabetes

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

Preventive placement of ICDs improves survival in patients with less severe heart failure

Researchers discover new way by which metabolism is linked to regulation of DNA

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Scientists discover 23 new genes linked to heart rhythm

Use of catheter ablation lowers risk for atrial fibrillation

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News